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Abstract
Amgen is attempting to increase the impact that its products make in people's lives. To meet this goal, the
company is aggressively working to reach more patients through growth opportunities in international
markets and expects to significantly increase its existing footprint and product impact over the next
several years. While the current market entry practices for emerging markets are meeting Amgen's needs,
rapid expansion poses significant challenges. This thesis explores two primary aspects, the investigation
of improvement opportunities in the commercialization of emerging markets and the development of a
risk assessment model applicable to new market commercial entry. Both aspects relate to the larger
problem of rapid international expansion and support its resolution in different forms.
The assessment of improvement opportunities for emerging market commercialization strives to develop
a tangible set of actions the organization can take forth in order to enhance the planning and execution of
new market entry. The analysis is accomplished through an in depth study to determine the current level
performance for commercial market entry. Based on the current state determination, a future vision is
established which incorporates fundamental principles of operational excellence methodologies,
integrating various techniques to develop a cohesive approach for improving current entry practices. An
improvement roadmap is developed, detailing out specific actions, utilizing a phased implementation
approach that allows for making incremental improvements.
The risk assessment model establishes a tool the organization can utilize in order to properly identify risk
associated with emerging market entry and enhance the decision making process that occurs at a senior
leadership level as to whether or not a country should be entered. A scenario based evaluation
methodology integrates cross-functional expertise across the organization assimilating information that is
normally isolated to a small group within the company. The model determines risk levels for each
scenario, generates a risk report and an output review is conducted with subject matter experts (SME) and
functional leads. Scenarios that potentially require remediation are reviewed in a detailed risk assessment
and resolved as necessary. Any substantial cost associated with control efforts are incorporated into the
financial analysis for the target launch country, providing a better depiction of cost versus reward. Thus,
the model increases the firm's ability to make agile risk-informed market entry decisions while providing
a standardized method that is scalable cross-regionally.
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1 Company Background
In 1919, Hungarian agricultural engineer, Karl Ereky, developed the term biotechnology, combining
biology and technology, to mean the application of biology to convert raw materials into useful products
for humans. The biotechnology industry began during the 1970s in California and Amgen was founded
less than a decade later. Amgen primarily produces biotechnology medicines in the form of large,
complex molecules comprised of proteins as compared to small molecule medicines comprised of
chemical compounds.
The chapter will provide an overview of the company, followed by a review of the international
expansion effort and conclude with the organizational structure relevant to the thesis.
1.1 Amgen Overview
Amgen is a market leader in discovering, developing and providing human therapeutics within the
biotechnology industry. With a primary organizational mission to serve patients, the company has
repeatedly put the patient first. Amgen's products have changed the medical industry, helping patients
fight serious illnesses such as cancer, arthritis, kidney disease, bone disease and other potentially
devastating ailments. Amgen is an active innovator with a number of promising new medicines in its
robust pipeline. The company is committed to advancing science-based medicines and continues to
demonstrate its commitment through sustained innovation, attained in part through university research
and strategic partnerships.
Amgen utilizes precise manufacturing of biological medicines to construct a portfolio of nine primary
products under ten brand names distributed across markets worldwide: Aranesp@ (darbepoetin alfa),
Enbrel@ (etanercept), EPOGEN@R (epoetin alfa), Neulasta@ (pegfilgrastim), NEUPOGEN) (Filgrastim),
Nplate@ (romiplostim), Prolia@ (denosumab), Sensipar@ (cinacalcet), Vectibix@ (panitumumab) and
XGEVA® (denosumab).
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Amgen is a California based corporation, founded in 1980, with its headquarters in Thousand Oaks,
California. Currently, Amgen supplies its life saving therapeutics in over 75 countries, employs
approximately 18,000 employees globally, and has revenues of approximately $17.3 billion (2012).
Additional information regarding Amgen can be found at www.amgen.com.
1.2 Reaching More Patients through International Expansion
A primary corporate goal over the past several years at Amgen is to increase the number of patients that
have access to the company's lifesaving medicines. As a United States based company, Amgen has
traditionally focused on the domestic market and European markets. Some emphasis has been placed on
international markets but the organization is arguably underpenetrated in the international market space
compared to its competitors and parallel markets. To close this gap in international market penetration
and more importantly reach more patients, the company has embarked on an effort to aggressively make
its products more accessible in international markets. This consists of an international expansion effort
that sets forth to significantly increase the number of countries in which the company operates and to
increase the product offerings available in existing or newly entered countries. The drawback to the rapid
international expansion effort is that such an initiative presents a significant challenge to the company
when there are a limited number of resources allocated to new market entry activities. The result has
created a segmented regional structure, in varying states of maturity, which have independently developed
standards for how entry should be assessed and execution conducted. Proper management and reporting
of the regions has proven to be difficult as each region has continued to grow in scale and individual
regional complexities are beginning to have an adverse impact on the organizations ability to effectively
penetrate new markets.
1.3 Organizational Structure
As a relatively young company in the industry, Amgen has made a substantial impact in a short amount of
time. Having the feel of a startup but with the scale of a multinational organization, Amgen has been able
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to make agile decisions and remain quite profitable. The company is comprised of three primary
divisions: Research and Development, Operations, and Marketing. Within the Operations organization,
the Global Supply Chain (GSC) group is responsible for actualizing the goal to increase market
penetration in international markets with the close collaboration of the International Quality group. The
GSC group consists of functions that support planning, scheduling and distribution, as well as internal
improvement groups tasked with enhancing the entire value chain cross-regionally. The international
expansion efforts within the GSC group are comprised of five primary units: European Union, Middle
East Africa, Latin America, Asia (Region 1, Region 2, Region 3, and Region 4 respectively) and Alliance
Management. Each unit supports global delivery of Amgen products produced at the company's
manufacturing sites. During the internship European Union, Middle East Africa, and Latin America
regions were currently active in commercialization efforts for international markets and the Asian region
is in the strategic development phase. The Alliance Management group primarily utilizes partnerships
with third parties to manage and distribute products within specific markets. For the purposes of this
thesis, the concepts employed are only applicable to the European Union, Middle East Africa and Latin
America regions due to their current state of development. It is worthwhile to mention that at a corporate
level, Global Operations Teams (GOT) have oversight for specific products within the Operations
division, yet depending on the unit, varying structural forms are utilized for resourcing within the GSC
regions. Certain regional units establish resources based on product type, aligned with the GOT structure,
whereas others are oriented by geography.
1.4 Thesis Outline
This document is organized into six chapters:
* Chapter one provides an overview of Amgen and the biotechnology industry. Pertinent
background information is provided relating to Amgen's products, mission and organizational
structure.
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" Chapter two describes the context of the problem faced by the organization, the objective of the
project and how the research was conducted.
* Chapter three gives an overview of the literature that was consulted to formulate the two research
areas into a cohesive structure.
" Chapter four details the Emerging Market Entry Process Analysis utilizing the DMAIC Six
Sigma improvement framework to describe the process.
" Chapter five describes the Emerging Market Entry Risk Assessment Model, reviewing the
previous process, model development, functionality and limitations as well as a recommended
process for sustainment.
" Chapter six closes the thesis with key takeaways that were provided and potential future work
from each research area.
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2 Introduction
The content presented in this thesis outlines the results of a six month internship with Amgen Inc. from
May 2012 to December 2012. The internship was championed by the Global Supply Chain (GSC) group
with a task to investigate the impact of Amgen's intemational expansion efforts on the company from
emerging market entry commercialization. Two major problems were targeted as a result of rapid
emerging market entry, including market entry practices that were not effectively executed, and
management's lack of complete information to make risk-informed entry decisions.
During the six month period the internship was based at the company headquarters in Thousand Oaks,
California. However, due to Amgen's current network, many sites across the globe were involved
extensively. This consisted of a cross-functional and multi-site team to develop and streamline an
approach which could be utilized to resolve the targeted challenges associated with rapid international
expansion due to emerging market commercialization. Additionally, a pilot project was conducted to
develop and validate an Emerging Market Entry Risk Assessment Model (EMERAM) which could be
used to enhance management decision making, but piloting was omitted for improvements identified for
the execution of market entry practices.
2.1 Problem Statement
Amgen has embarked on an effort to increase the impact that its products make in people's lives. To meet
this goal, the company is aggressively working to reach more patients through growth opportunities in
international markets and expects to significantly increase its existing footprint and product accessibility
over the next several years. While the current market entry practices for emerging markets are meeting
Amgen's needs, rapid expansion poses two significant challenges that have been targeted and will be
explored for the commercialization of new markets:
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1. Market entry processes are underdeveloped for emerging markets and lack alignment across the
regions and functions established in the company, thus impacting the effectiveness of commercial
planning and execution.
2. The current risk assessment method for emerging market entry needs maturity to ensure
objectivity and provide purposeful risk-informed management decision making.
In order to successfully increase the impact the company and its products make at a global level, Amgen
must continue to expand its international footprint into emerging markets. The desired expansion can only
be accomplished if the company is able to overcome the challenges associated with highly variable
regional practices and local market requirements. Without such improvements, the organization will face
substantial costs and decreased efficiency. To overcome such obstacles, Amgen must embrace the
integration of operational excellence principles into emerging market entry commercialization practices
and introduce an enhanced emerging market entry risk assessment framework.
2.2 Project Objectives
The thesis will explore the risks and challenges associated with emerging market entry commercialization
for a biotechnology company such as Amgen. The results of the thesis will provide valuable insight into
methods which can be incorporated to enhance the effectiveness of Amgen's international expansion
efforts through two primary research areas and associated objectives:
1. Emerging Market Entry Process Analysis
" Investigate and document the current emerging market entry commercialization process to
assess opportunities for improvements.
* Utilize Six Sigma improvement Define-Measure-Analyze-Improve-Control (DMAIC)
methodology to establish improvement opportunities and report project progress for
commercial entry into emerging markets [1].
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* Develop future state improvement roadmap with a time bound action plan, to streamline
emerging market entry commercialization execution through the integration of operational
excellence principles, for execution by the Global Supply Chain unit.
2. Emerging Market Entry Risk Assessment Model (EMERAM)
" Assess the current risk assessment methodology to evaluate the effectiveness for its use in
providing risk-informed decision making
e Develop a risk assessment model for use in analyzing potential risks associated with
emerging market entry commercialization and provide key stakeholders with risk-informed
market entry decisions
e Establish a global platform and supporting process for integration of the risk assessment
model into Amgen's governance phased-gate review process
The emerging market entry commercialization process is divided into six business phases: Business Case,
Commit to File, Submit File, Commit to Launch, Launch, and Life Cycle Management (LCM). For the
thesis, the scope of commercialization phases studied span from Business Case development up until
launch. The image shown in Figure 1 provides a visual depiction of the two research areas and the
relation to the emerging market entry commercialization process. Each research area sets forth to alleviate
the problem of international expansion through rapid emerging market entry yet targets different aspects
of the larger problem.
18
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Figure 1: Primary Research Areas and Commercialization Phases
2.3 Research Methodology
Due to the nature of the project and differing target goals of the overall problem of rapid emerging market
entry, differing methodologies were used for the respective research areas. Each approach is outlined
below:
1. Research Area 1 Methodology - Emerging Market Entry Process Analysis:
The Emerging Market Entry Process Analysis utilizes the continuous improvement Six Sigma
DMAIC methodology to establish a set of recommendations with a supporting implementation
improvement roadmap. The roadmap seeks to establish a path forward by providing time bound
tangible actions for the organization to act upon the primary improvement opportunity findings
associated with the emerging market entry commercialization process. The research area has five
phases with the associated objectives of each phase outlined below:
1) Define Phase - Gain agreement on project scope, deliverables and develop formal research
area goal
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2) Measure Phase - Determine the current performance of the market entry process, establish
new metrics as appropriate and set targets for future state performance
3) Analyze Phase - Discover the primary root causes which inhibit the execution of the market
entry process. Integrate varying sources of information to develop a holistic understanding of
the current mode of operation. Primary sources of information consist of a voice of the
customer analysis, interviews of subject matter experts (SME), data analysis and existing
documentation review.
4) Improve Phase - Institute a framework supported by the development of an improvement
roadmap containing detailed actions that can be taken by the organization to incorporate
improved project management and operational excellence philosophies.
5) Control Phase - Determine efforts that can be made to maintain and enhance improvements
to the implementation roadmap as well as opportunities for future work.
2. Research Area 2 Methodology - Emerging Market Entry Risk Assessment Model:
The Emerging Market Entry Risk Assessment Model Analysis utilizes standard risk quantification
and management techniques to establish a scenanio based evaluation methodology. To develop the
model, risk scenarios for emerging market entry commercialization were pre-determined with the
support of subject matter experts and held constant for each new entry risk assessment. Components
of risk were assessed to determine the most appropriate method to evaluate each risk scenario. Risk
quantification methods supported the classification of scenarios utilizing the risk matrix or risk
mapping methodology. The research area has six phases with the associated objectives of each phase
outlined below:
1) Current state process - Baseline and document the current methodology utilized for
evaluating and communicating risks associated with emerging market entry
commercialization
2) Define model goal - Determine scope of work to be completed, formal research area goal and
applicable modes of entry
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3) Model elements and functionality - Determine the aspects necessary to properly identify and
assess risks, and incorporate the necessary model functionality to support a robust risk
assessment
4) Process for use - Develop a process for proper model usage and create associated
documentation
5) Validation and enhancements - Pilot model and make improvements based on pilot results
6) Integration - Develop proposal for integration into companywide review process and align
with senior management expectations
21
3 Literature Review
Prior to developing the emerging market entry process analysis framework and the EMERAM, a
significant amount of effort was expended in order to research the existing approaches applicable to each.
There is a substantial amount of literature on the topics of operational excellence and risk management
practices with a number of differing approaches. Operational excellence methodologies span from
approaches such as Six Sigma or the Theory of Constraints (TOC), to those less familiar such as Demand
Flow Technology (DFT) [2]. Risk management approaches utilize various methods to quantify, prioritize
and ultimately minimize the occurrence of a potential risk outcome. Each approach has limitations and
critiques as to why one approach may be more suitable over another. In the following sections, a review
of relevant aspects to each topic will be covered.
3.1 Operational Excellence Methodologies
The concept of operational excellence is a philosophy driven by the leadership in a company with a focus
on how an organization can utilize continuous improvement concepts to develop a systematic and
sustainable approach to making tangible improvements in its long term enterprise performance. The
emerging market entry commercialization process can be viewed as a type of production process for
which the operational excellence methodologies reviewed in this section are applicable. Generally,
metrics are established in the organization which aligns the company to focus on the vital few
components of performance that will help the company to achieve its aspirational organization. This can
be paralleled to the Pareto principle of focusing on the vital few, to largely achieve the results that are
desired since in many instances approximately 80% of effects arise from 20% of the causes [3]. An
additional assumption is that the metrics of organizational performance for operational excellence must be
aligned with the rewards for individual performance to ensure that there is not a conflict in the incentives
that drive individual behaviors [4]. Many methodologies exist for how an organization should go about
implementing operational excellence, namely in the form of continuous improvement approaches. Yet no
recognized approach is credited with being the dominant model. Rather it is generally more appreciable to
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utilize a combination of approaches to attain a desired objective. The Theory of Constraints (TOC) school
of thought claims that to make improvement, the process constraint or bottleneck should be the primary
focus. That is, in order to achieve the ultimate goal of the company to make money, the limiting factor in
the process must be exploited in order to achieve the maximum throughput in the entire system. This can
take form internally in the process or outside of the scope of control, those being limitations in market
demand or material supply [5]. The lean approach to continuous improvement states that muda or waste
should be the focus of improvement. Originally, waste was identified as occurring in seven forms:
transportation, inventory, motion, waiting, over-processing, over-production and defects [6]. However,
through continued use of the lean methodology, an eighth form of waste has been identified, latent skill or
human potential. It is argued that in order to make improvements in the seven wastes, an organization
must capitalize on employee creativity [7]. Lean is sometimes compared to the scientific method in which
an organization conducts controlled experiments to make change [8]. Through the use of lean, waste can
be driven out of the system to achieve enhancements in performance. The Six Sigma approach to
operational excellence seeks to optimize the quality of process outputs and to drive variability out of the
system through the identification and removal for causes of error [9].
Each of the approaches has been critiqued for having shortcomings as to how best make improvement in a
system. The limitation of the TOC approach is that if only the constraint is focused on, then there is
suboptimal performance within differing aspects of the process or system. This is a concerning issue, not
only from an efficiency standpoint, but in situations where multiple steps in the process are closely
constrained or a wandering bottleneck exists. Lean is criticized for not prioritizing where the focus should
occur and that with a limited number of resources it is not feasible to drive all waste out of a system. Six
Sigma methodology falls short in that it seeks to only optimize a process which may not need optimizing
and does not provide a strong set of tools in order to select prioritization efforts [9].
As a result of the shortcomings in each improvement philosophy, there is no dominant framework that
can be universally applied to attain the desired results in all types of systems. Instead, it is more ideal to
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integrate these philosophies into a cohesive framework which allows for the ability to make overarching
improvements as best determined by the desired system enhancement and need of the organization.
Utilizing a combination of TOC, Lean and Six Sigma (TLS) can allow for the creation of an improved
system. Through the use of TOC, a system constraint can be identified and the organization can focus on
the aspects that matter to shareholders. The application of Lean allows for the system constraint to be
exploited by removing or minimizing the process waste. Finally, through the application of Six Sigma,
the system constraint capacity can be elevated, thus increasing system throughput by systematically
optimizing the process at the system constraint, through the removal of waste and enhanced quality. Thus,
there is no dominant approach, but rather through the utilization of multiple methodologies, it is possible
to achieve a state of operational excellence within a system [10].
3.2 Queuing Theory
Queuing theory is the mathematical study of queues or waiting lines [34]. Amgen's commercialization
process for emerging markets can benefit from the application of queuing theory in that there are
competing demands for the limited resources in the entry of new markets. Thus jobs can back up the
system, constrain resources and overload the organization. A queuing system consists of discrete objects
that may be called items which arrive at a given rate into the system, generally denoted as A [28]. Arrival
rates vary but often a Poisson process for the number arrivals (or equivalently an exponential distribution
for the time between arrivals) is assumed to provide an arrival pattern which represents a real-life system
and provides sufficient accuracy [35]. A Poisson process requires not only independence of time intervals
but independence of the time since the previous event on the time to the next event. Thus under a Poisson
process it does not matter if there have been one, two or three time units since the last one, the distribution
until the next one still remains the same. In this sense the process is what is known as a memoryless
process. Within the queuing system items form a queue when a system resource or server is blocked or
utilized and enters service at based on the number of servers and mean service rate often denoted c and p
respectively. Once serviced, an item exits or departs the queuing system. Utilization, denoted p, is a
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measure of system resource usage to the units which arrive at the resource. The formula for utilization
takes the proportion of the mean arrival rate over the product of the mean service rate and the number of
servers, that is [35],
Utilization should be less than one for a system to properly function and if it is greater than one the queue
will explode, growing at the rate of arrival as time progresses. A lower utilization rate corresponds to a
reduction in queuing for units in the system, but in some cases may be considered inefficient as the
system has a larger proportion of time in which is remains idle.
Little's Law is a queuing theory theorem which states that, under steady state conditions, the average
number of items in a queuing system is equal to the product of the average arrival rate and the average
time an item spends in the system. The formula for Little's Law is shown in the equation below, where L
represents the average number of items in the queuing system, 1 as the average arrival rate per unit time
and W as the average waiting time [28]:
L = AW
The theorem is regarded as quite simple yet a remarkable result since the relationship is not influenced by
the number of servers nor the queue orientation, the arrival distribution, the service distribution, or almost
anything else [36]. The simplicity of the formula allows for it to be extremely powerful and useful
equation, supporting "back of the envelope" calculations.
3.3 Risk Management Approaches
Risk management is a philosophy which aims to identify, assess and prioritize risk through the organized
use of resources, in order to control, monitor or mitigate the probability of an incident's occurrence [11].
Risk management approaches are valuable to Amgen in order to systematically assess and ascertain
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relevant risks to the company due to emerging market commercialization. Risk categorization is a method
used to systematically organize risks in order to identify the root causes in a consistent manner. There are
a number of different suggested groupings to categorize risk which largely varies between literature
source and organizations. Such examples can occur due to a variety of factors but are commonly
researched in categories relating to financial risks, natural disasters, geo-political risks, intellectual
property, and transportation and logistics. The Risk Breakdown Structure (RBS) is a method utilized to
logically enumerate risks relating to a specific risk category, into subcategories in order to achieve an
exhaustive list of potential failures [12]. A number of risk management standards have been developed by
organizations such as the Project Management Institute (PMI) or the International Standards Organization
(ISO) as well as government organizations such as NASA or the DOD [12] [13][14][15]. Each technique
generally varies in form depending on risk application, yet there are several aspects that are common
across most approaches. Generally risk management approaches assess risk in the form of severity of a
risk and probability of its occurrence. A risk matrix is useful in allocating combinations of severity and
probability of occurrence to classify a risk level [14]. Some techniques also include the use of a
detectability factor, such as the FMEA methodology [16]. Risks are generally monitored, and progression
is tracked through tools such as a risk register, which identifies a risk, assigns action and ownership, and
is used to monitor the risk until it is resolved [17]. Additionally, a risk register can be used to create a
visual representation to communicate and prioritize risk control efforts in the form of a risk severity plot.
An example of a risk severity plot is shown in Figure 2 where each diamond represents an individual
identified risk that has a functional owner. Generally it is recommended to take action on risks that are
plotted within the top right quadrant. In all forms, risk management seeks to minimize the impact of a risk
and communicate risk prioritization to relevant parties.
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Figure 2: Risk Register Graphical Example
3.4 Review of Related Theses
A number of theses have been written on topics which relate to both operational excellence as well as risk
management. The Leaders for Manufacturing (LFM) program thesis, Development of a Total Landed
Cost and Risk Analysis Model for Global Strategic Sourcing, by Brian Feller describes the process used
for creating a total landed cost and risk model for application of strategic sourcing employed at
PerkinElmer, Inc [18]. The thesis provides the details of the aspects relevant to constructing a risk model
for evaluating a supplier, considering 20 different factors to develop a risk portfolio. The risk portfolio is
useful in supporting the decision making process when multiple suppliers are considered for a sourcing
decision. A systematic approach to determining and monitoring risks in a similar method to that of the
risk model developed by Feller will benefit Amgen's efforts in emerging market commercialization.
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Risk Severity Plot













The Leaders for Global Operations (LGO) program thesis, Optimization of SKU Creation Process and
Adherence Improvement through use of Workflow Management, by Richard Gimilin, was useful in its
review of the initial development of a work flow tool that was used to manage the project management
aspects of the commercialization process for emerging market entry [19]. Prior to implementation of the
tool, the entry process was managed utilizing Microsoft Office software. This method was a labor
intensive approach without mistake proofing features to minimize error. Gimlin's thesis identified the
activities mapped to the current state process, identified aspects essential to the commercialization project
management process and developed a tool to automate and streamline the activities. Much of his work
paralleled the author's internship project, in that it related to the same process of emerging market entry
commercialization and delved into aspects necessary to execute new entry.
Finally, the LFM program thesis, Development of a Global Facility Location Analysis Tool, by Briana
Johnson provided an approach for a location decision support analysis utilizing the Analytic Hierarchy
Process (AHP) [20][30]. The thesis provides a review of the factors associated with facility location and
how the use of the AHP process supported qualitative tradeoffs of individual sites in quantitative form to
determine an optimal facility location selection. The inclusion of an AHP process or similar methodology
can improve the allocation of resources for the prioritization of new target country entries for emerging
markets.
3.5 Chapter Summary
After reviewing a number of literature sources for approaches on operational excellence, queuing theory
and risk management, two main themes occurred. First, the methodologies for continuous improvement
and queuing theory must be integrated in order to develop a robust framework for improvement. Second,
the risk management techniques that exist each attempt to minimize the occurrence of a risk event, yet no
dominant model or tool has been proven to be substantially more impactful than another. The optimal
application of operational excellence, queuing theory and risk management methodologies is found not
through an individual approach, but rather through the selection and use of a method that can be
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successfully applied in an organization. This means that although certain solutions will bring more merit
in one organization, they may not be as beneficial in another. Thus, having a methodology or set of
methodologies that can be accepted by the company will directly impact the firm's success with a given
approach.
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4 Emerging Market Entry Process Analysis
The Emerging Market Entry Process Analysis consisted of an assessment to determine improvement
opportunities in Amgen's management and execution of new market entry commercialization for
emerging markets. The Six Sigma Process Improvement DMAIC methodology was used as the
framework to manage the assessment of this research area. This approach was chosen as it provides a
foundation for a structured project approach, specific tools which can be utilized, and is most appropriate
when the intent of the project is to make enhancements or improve an existing process due to inadequate
performance [21]. In the following sections, the DMAIC phases will be discussed and more specifically,
how they were used as the project methodology to understand the current state and determine an approach
to improve the emerging market entry process supported by tools of the TLS improvement methodology.
4.1 Define Phase
The define phase was used to gain agreement on project scope, deliverables and ultimately develop a
formal project goal. The first step was to develop a clear understanding of the current state process for
emerging market entry. This aspect of the project was achieved through a number of actions to investigate
and collect pertinent process parameters. The investigation began by focusing on establishing the project
team and identifying the project champion. Then a stakeholder analysis was conducted along with
informational interviews to collect information at the functional levels of the organization. A review of
process documentation, available data and metrics and brainstorming sessions complimented the process
to clearly define the problem. A number of process mapping exercises took place utilizing methods such
as swim lane process mapping and Suppliers-Inputs-Process-Outputs-Customers (SIPOC) to document
the as-is process. The swim lane process map supported the identification of the current state process by
segregating functional process activities throughout specific commercialization phases. The SIPOC was
exceptionally helpful at determining the primary elements of the complex emerging market entry
commercialization process and defining the project scope [22]. The investigation concluded with
benchmarking efforts, site visits to the international expansion headquarters and literature reviews of
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relevant matters. The current state process map for the emerging market entry commercialization process
can be seen in Figure 3 below. It is worthwhile to mention that the site visit to the international expansion
headquarters was critical as the vast majority of emerging market entry launches and order fulfillment
occur through this location.
Figure 3: Current State Process Map
After reviewing the relevant aspects of the process, it was agreed that this research area goal would be to
develop an implementation roadmap for integrated operational excellence into the emerging market entry
process. This would allow for a standardized emerging market entry process to be developed that attempts
to maximize process execution in terms of cost, speed and quality. The final output of this phase was a
project charter and project timeline for the emerging market entry process analysis.
4.2 Measure Phase
The measure phase was vital in determining the current performance of the commercial market entry
process and setting targets for the future. Stakeholder interviews and team focus groups were used to
determine and agree upon the project Critical to Quality's (CTQ). This required the involvement of a
large number of organizational functions including international quality, global supply chain,
transportation, planning and scheduling, shared services, legal, project management, commercial
operations and regulatory affairs. An extensive discussion ensued during these meetings, in order to
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ensure that there was perceived value in each measurement that would be included. All established
metrics related to cost, speed or quality of commercial market entry execution. The specific metrics
identified for the project are listed in Figure 4.
Speed I Cost
BC Initiation - BC Submission
BC Submission - BC Approval
BC Approval - CtF Approval
Cycle Time CtF Approval - File Submission
File Submission - MAA
MAA - CtL Approval
CtLApproval - Launch
Total Throughput Time (TTPT) BC Initiation - Launch
Numberof open filings per region per month
Numberof open filings per project manager per month
Work in Progress (WIP) Number of open launches per region per month
Number of open launches per project manager per month
Number of open maintenance per region per month
Numberof open maintenance per project manager per month
Utilization Resource utilization time / Available time
BC = Business Case
CtF = Commit to File
MAA = Marketing Authorization Approval
CtL =Commit to Launch
Cost of Quality Prevention Costs
Appraisal Costs
Cost of Poor Quality Internal Failure
Extemal Failure
Dollars / Launch
Cost of Launch Dollars spent on due diligence
Dollars spent on resourcing
Unplanned resourcing! management intervention
Customer concessions / discounts
Fees Legal Fees
Penalties: liquidated damages, fines
Dollars of Scrap
Planning Dollars expended due to Margin Slippage / Erosion
Dollars expended due to Delays
Forecast Accuracy
Quality
First pass yield Yield per execution phase
Rework Percentage of Rework
Scrap Product scrap
Figure 4: Project Critical to Quality's (CTQ's)
To define performance standards, it was first necessary to determine baseline values for each CTQ. This
information was gathered through data mining of information systems and databases then taking the
average of each measure. The primary systems utilized were the company enterprise resource planning
software and the operations performance database. After baseline values were determined per CTQ, target
improvements were set. The deliverable of this phase was to establish the metrics which would be used to
assess the effectiveness of the improvements made to the emerging market entry process.
Due to the long duration of the commercialization process, it was not possible to conduct a Measurement
System Analysis (MSA) during the course of the internship. A MSA is an experiment beneficial for
identifying sources of variation in a measurement. The goal is to validate the repeatability and
reproducibility of the system for each identified CTQ [1].
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4.3 Analyze Phase
During the analyze phase, the objective was to determine the primary root causes which inhibit the
execution of the market entry process. The first step in root cause determination was to establish the
emerging market entry process capability. Data sampling and basic statistical analysis allowed for the
determination of current launch performance within some degree of statistical certainty. The analyzed
data was segmented and stratified by region, resource and product to determine potential trends. It is
worthwhile to mention that when analyzing the coefficient of variation for the processing time of
commercialization activities associated with emerging markets, values substantially larger than one were
determined for regions 1, 2 and 3. The coefficient of variation (Cv) can be used as a measurement of
commercialization launch distribution dispersion and defined as:
CV-
IA
Generally, a distribution with a coefficient of variation of 1.0 or below is considered low-variance [23].
The coefficient of variation values indicate that when the standard deviation of the commercialization
process time, for each product launch in the emerging market entry process, is compared to average
commercialization process time, it is several orders of magnitude higher. A major component of the
variability within the commercialization process can be attributed to various forms of execution delays.
Thus, the findings from the process capability assessment determined that the entry process is highly
variable based on launch region, resource and organizational priority.
To investigate the opportunities further, a number of Six Sigma and continuous improvement tools were
utilized to support deeper investigation. This consisted of a brainstorming session to develop a Current
Reality Tree (CRT) to qualitatively identify the root cause(s) of improvement opportunities relating to the
commercialization process through the identification of undesirable effects [24]. The outcome from this
exercise was that the group of participants viewed themselves as being overburdened with work and thus
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their ability to complete a job effectively was negatively impacted. This was primarily associated with the
inability of various functions to communicate available capacity and plan launch activities accordingly. A
fishbone or cause-and-effect analysis allowed the team to delve further into the causes for resource
overburdening [25]. The major themes from the analysis identified complexities in available resources,
process variability and information availability as seen in Figure 5.
-Environment
Figure 5: Cause-and-Effect Diagram - Resource Overburdening
Finally a Pareto analysis was conducted to analyze the reason codes for execution delays [3]. As shown in
Figure 6, the findings of the Pareto analysis indicate that overscheduling of resources and incomplete
information are the major causes of execution delays in the commercial entry process. In essence, this can
be attributed to high levels of Work in Process (WIP), which result in overutilization of resources, causing
an impact on the quality of work that is performed.
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Figure 6: Pareto Analysis of Reason Codes for Execution Delays
After the initial assessment of the process capability it was necessary to conduct a deeper analysis to
determine the reasons for execution inefficiencies. The next sections will detail the process for the Value
Stream Map (VSM) Analysis, Constraint Identification Analysis and primary sources of variation.
4.3.1 Value Stream Map Analysis
The VSM exercise consisted of a cross functional group of SMEs in a multiday workshop. To prepare for
the session, participants were given pre-read information which contained items relating to the project
background and current state analysis, and were asked to bring pertinent process documentation and data,
and most importantly, an open mind. It is important to note that this was an abbreviated VSM exercise
due to the resource constraints and conflicting priorities of the organization. A detailed description of the
VSM process can be found in, Learning to See, by Mike Rother and John Shook [26]. An image of the
VSM under development can be seen in Figure 7 below.
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Figure 7: Value Stream Map under development
The VSM analysis provided detailed insight into the material and information flows which comprise the
emerging market entry commercialization process. This was important as the initial process map and
SIPOC created during the define phase omitted pertinent details such as cycle times, WIP and customer
demand, which was then translated to the required takt time needed to meet launch demand. Further the
VSM activity allowed for potential identification of the process constraint which is critical to proper
management and execution of the launch process and will be discussed in the next section.
4.3.2 Constraint Identification and Management
The VSM analysis was a useful input into the identification of the emerging market entry process
constraint as it provided indicators as to where the process bottleneck may exist. The initial identification
of the constraint was based on the average cycle time duration for each process step and the average WIP
level prior to a given process step. Based on this analysis the constraint is identified as being located prior
to the file submission at the local country regulatory organization. Aside from the cycle time and WIP
analysis, this is somewhat of an intuitive occurrence as the review duration of this step in the process is
outside of the organization's control. The regional aggregate of average cycle time as a percentage of total
throughput time, and associated WIP levels as a percentage of the entire WIP, is shown in Figure 8.
36
Business Case 28% 30%
Commit-to-File 21% 16%
Submit File 33% 38%
Commit-to-Launch 19% 17%
Figure 8: Cycle Time and WIP Constraint Identification
Upon further analysis and validation of the speculated process constraint, an interesting occurrence was
discovered. In several emerging market entry launches, the process constraint was not found within the
local country regulatory organization, but was found at various points further upstream in the process,
most commonly the business case and due diligence steps. Such a finding warranted a deeper
investigation to uncover the true process constraint. Queuing theory supported this observation through an
understanding that within a serial system the relative value of WIP to throughput time is not necessarily
an indicator of the system bottleneck. Through the consultation of literature on constraint management,
primarily the Theory of Constraints (TOC), it was found that the emerging market entry
commercialization process must be properly managed in order to gain control of the entry process and
minimize high variability in execution performance. Fluctuations in product and volume mixes, as per
individual commercial market, result in the wandering bottleneck phenomenon. A process step is
designated as a bottleneck when it has a work load larger than its capacity. This phenomenon is an
outcome attributed to the overuse of resources and can be observed through the high WIP and resource
utilization levels. The consequence of high WIP and resource utilization levels is that over long periods of
time the system bottleneck shifts from one resource to another [27]. To properly treat this process
symptom, it is necessary to eliminate variability due to self-inflected plans based on the need to keep WIP
or utilization levels high. A simple solution proposed for remediating the wandering bottleneck
phenomenon is to limit the amount of WIP in the entire system at a given time. If implemented
successfully, the result is a system that maximizes throughput by proper allocation of work based on
available capacity. Treating the emerging market entry commercialization process in order to minimize
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the wandering bottleneck phenomenon allows for proper development of the future state commercial
entry process. This will be discussed further in Section 4.4 Improve Phase and the Future
Commercialization Vision.
4.3.3 Identification of Variation Sources
After identifying the process constraint locations, it was essential to determine the sources of variation in
the commercialization of emerging markets to make improvements to the process. Three primary findings
are attributed to the inefficiencies in the current state commercialization process:
1. Lack of Standardization
2. Prioritization
3. Resourcing
The first finding, lack of standardization, is an important source of variation and a pertinent finding since
it is not possible to make improvements to a process unless it is stable and under control. For the
emerging market entry commercialization process to be stable and in control, actions were taken to
analyze opportunities in which the process and its governance could be standardized. To clarify, the
governance process is a periodic review of pertinent country launch information conducted by the
leadership team in a phased gate model. The output of the governance process is a "go" / "no-go"
decision or any rework required before proceeding to the next phase of implementation. The primary
elements determined that contribute to the lack of standardization consist of aspects relating to an ill-
defined market entry and governance process. Most notably, there are no formally established policies,
procedures or guidelines detailing how the process should work and when aspects of a given step should
occur. There are also no clearly defined roles or responsibilities for the various parties involved in the
commercialization process. As a result, market entry processes for emerging markets vary significantly
between regions as they are in essence, "homegrown" and customized, as a given region develops over
time. It is a complex organizational structure in which certain regions are organized, based on geography
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or product. The outcome of the standardization analysis identified that there are inconsistent processes
and procedures which vary significantly between each established region., Thus, the total duration of the
emerging market commercialization process is negatively impacted by the lack of process
standardization, resulting in incomplete or incorrect information that is provided to governance for entry
assessment review.
The next major finding, prioritization, identified sources of variation in how the organization plans and
monitors the launch activities for emerging markets. From a planning perspective, the company based
project plan timelines on corporate company goals for entry into new markets. The resultant approach
presents potential problems for the execution of commercial market entry. Without an analysis to
understand available capacity which support emerging market launches, project plans can generally be
expected to fail. The metrics and associated incentives established in the process are created such that
they support volume or number of launches and do not monitor effectiveness of the process. Over time,
the organization has attempted to cope with the overburdening of resources, yet constraints in capacity
limit the ability of the firm to manage the launch and ultimately delay a new country commercial entry.
These occurrences have become the norm causing unrealized planning schedules, diminished
responsibilities and limited accountability for results. If a launch schedule is not compromised, then the
plan is maintained through excessive cost generation. This generally occurs through additional resources
and by deprioritizing ongoing launch activities, creating excessive WIP and multitasking.
Unwarranted WIP has negative implications on throughput time, thus causing unnecessary process delays.
This is demonstrated in Little's Law through the equation below, where L can be regarded as the system
WIP, A as the throughput time and W as the cycle time [28]:
L = AW
Further, as proposed by Goldratt in his novel, Critical Chain, excessive multitasking delays a task
duration due to unnecessary work and lack of focus that is required when changing between tasks [29].
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The excessive WIP levels can be observed in Figure 9 utilizing Little's Law, the commercialization
average target throughput time and the average cycle time per business phase to calculate a target WIP
level which is then compared to the actual level for each region.
Business Case Phase Commit-to-File Phase
- WIP
-Target
Region 1Region 2 Region 3
Submit File Phase




Region 1 Region 2 Region 3 Region 1 Region 2 Region 3
Figure 9: Work in Process (WIP) by Region by Business Phase
Finally, the selection of commercialization efforts and the target launch date for a given country is made
solely by the commercial organization. There is little to no involvement of the various functional
counterparts in the Operations and Regulatory organizations. This is problematic, again due to capacity
limitations and the lack of information sharing or knowledge transfer that occurs when having a
collaborative selection process. The impact to the process is that there is a feast or famine effect where
observable volatility occurs through the peaks and valleys in the number ofjobs over an annualized time
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Figure 10: Launch Variability by Region Over Time
The final primary finding, resourcing, identified potential variation improvements that could be made to
the allocation and management of resources for commercialization efforts. Project resources for launch
activities are assigned based on the region an individual worker is assigned. With three regions active in

















allocation would be appropriate if commercialization efforts were equally dispersed across the regions.
Further compounding the issue is the fact that resources within regions are assigned to a specific set of
countries. Currently, region two and three represent the vast majority of emerging market
commercialization efforts. Figure 11 below shows the percentage of total commercialization launch








Region 1 Region 2 Region 3
Figure 11: Percentage of Total Commercialization Launch Efforts by Region
The result of a regional and country based resource allocation method under the current
commercialization plan is an imbalanced resource utilization workload across the established regions.
This causes resource contentions when assigning country launch projects to a given individual resulting in
overburdening of resources, limited information sharing and potentially compromising the quality of
work performed.
The last aspect of the resourcing finding was that the organization has not identified the process
constraints. Although this was discussed earlier in the chapter, the analysis and corresponding planning
has not been performed by the organization. This means that without an analysis of available capacity and
the determination of the process constraints, the organization cannot effectively plan and execute against
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the constraint. The implications are a reduction in system throughput, inadequate resourcing at the process
constraints, and over resourcing in other aspects of the market entry process.
4.4 Improve Phase and the Future Commercialization Vision
The improve phase consists of instituting a framework which an implementation roadmap of detailed
actions can be taken by the organization to attain a future vision of integrated operational excellence for
the commercialization of emerging markets. The aspects were broken down into each emerging market
entry commercialization business phase within project scope: Business Case, Commit to File, Submit File
and Commit to Launch. The roadmap was developed in three sequential improvement phases, which
coincided with the primary sources of variation findings discussed in Section 4.3.3.
The first improvement phase established was standardization and governance. This phase entails activities
that should be undertaken by the organization to create clear process guidelines as to how work should be
performed and when. Specifically, the first action in this phase will be to institute policies, procedures and
guidelines necessary to have a standardized emerging market entry commercialization process as well as
the supporting governance review. Further actions will need to be taken to achieve a standardized process,
which includes detailed process flows, supporting SIPOC, and clearly defined roles and responsibilities to
delineate work per function per individual. Finally, it is critical to introduce a workflow tool to
autonomously manage the process, streamline the inputs and provide standard cross-regional project
plans. More information on the introduction of a workflow tool for emerging market commercialization
can be found in the thesis, Optimization of SKU Creation Process and Adherence Improvement through
use of Workflow Management by Richard Gimlin [19]. From a process standpoint the above actions
support a consistent and repeatable process which allow for the standardized execution of emerging
market commercialization entry and provides a basis for advanced continuous improvement.
Additionally, with the advent of standardized entry practices and governance review process, the idea of
governance by exception is achievable. The "governance by exception" philosophy helps support the
proper use of senior leadership's expended time on emerging market decision-making and avoids
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overburdening by only conducting a governance review if a set of criteria are not met or an exception is
raised.
The second improvement phase developed was prioritization. The prioritization phase focuses on aligning
the organizational functions to properly select, schedule and monitor emerging market launches. The first
aspect of this phase is to develop a country pre-selection commercialization business phase and
methodology in order to prioritize the launch sequence of target countries. This is important since the
current method considers the emerging market process to have infinite capacity, assuming there is the
ability to handle as many launches simultaneously as needed to meet company entry goals. Two
methodologies were proposed in order to facilitate the process. The first method for country pre-selection
is the use of the Analytic Hierarchy Process (AHP)., a Multi-Criteria Decision Making (MCDM)
methodology. AHP allows for an objective assessment to be made based on a set of predetermined criteria
which are jointly agreed upon cross-functionally and weighted prior to selecting a new launch country.
The benefit is that it provides an unbiased valuation of how a country should be prioritized and limits
resource intervention on a per launch instance since it can be setup in an autonomous manner. A detailed
description of the AHP process and its application in strategic decision making can be found in, Strategic
Decision Making: Applying the Analytic Hierarchy Process by Navneet Bhushan and Kanwal Ra [30].
The second method proposed requires a more resource intensive effort of cross-functional personnel on a
per launch basis, but would be generally more familiar to the individuals in the organization. This method
requires a semiannual review process of proposed country launches for emerging markets and agreement
upon their priority through a democratic voting system. From a theoretical perspective this process would
be less ideal than AHP, but may be better received by the organization in practice.
The next focal area of the prioritization improvement phase focused on developing a methodology to
determine and communicate system capacity. Introducing the concept of capacity load planning would be
beneficial in supporting country pre-selection, and in general, the organization, since it creates a formal
resource modeling methodology. Additionally, commercialization launches can be scheduled based on
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available capacity and reallocated to different time periods when a given time interval is overscheduled,
thus balancing the load over time. An example of the capacity load planning and the process described














Figure 12: Capacity Load Planning Example
Generally, load planning should be based on no more than an 80% utilization of available time for
emerging market commercialization, but may vary depending on the assumptions used to determine
utilization rate. A load plan designated at 80% or less utilization avoids overburdening of resources,
allows for the allocation of miscellaneous activities, incorporates allowances for process inefficiencies
and most importantly, does not overload the system. As seen in Figure 13, as utilization and variability
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Figure 13: Throughput Delay Curve [311
The final aspect of the prionitization improvement phase is the introduction of operational efficiency
metrics which monitor commercialization effectiveness in terms of cost, speed, and quality. These metrics
should replace or augment the current measures which assess emerging market entry progress through the
commercialization phases, in terms of activities that support the overall volume and adherence to
schedule of launches. The 4.2 Measure Phase section provides details on the proposed metrics in Figure 4.
The last improvement phase created is resourcing and flexibility. This phase of improvement focuses on
activities to better manage the use of resources and provide flexibility in how they are utilized. The first
aspect of this phase is pooling and prioritization. A portion of the pooling process needs to be developed
by creating two emerging market job pools, a filing job and a launch job pool. The establishment of two
separate job pools is necessary due to the long durations and variability in cycle time between the filing
and launch commercialization business phases. Creating two job pools allows for a decoupling of the
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planning and execution processes. Decoupling these points is beneficial since detailed plans that allocate
specific resources for a time period of many months in advance of execution, will commonly incur
conflicts and the plans generally collapse prior to being actualized. Emerging market entry jobs are
prioritized in the pools using a color coding system of green, yellow and red to indicate completion
progress. The measurement for each respective color is calculated based on the percentage ofjob
completion divided by the time remaining until the job is due at the process constraint. A job color status
of red indicates a critical status with less than 33% of the time remaining until the project is needed at the
constraint. Similarly yellow and green comprise the other two thirds of the remaining time, with yellow
signifying a warning or monitor status and green meaning a normal status.
After creating the job pool, the final portion of the pooling process should be introduced. This involves
introducing a cross-trained resource pool that would allow the emerging market regions to act as a single
unit. The approach is beneficial for planning and execution purposes by providing flexibility in the
assignment of resources as opposed to the segregated regional structure that the organization currently
utilizes which limits adaptability to unplanned volatility. As previously mentioned in section 4.3.3, the
current regional structure causes imbalances in workload, over or under-utilization of resources, and lack
of information sharing or silos of knowledge.
The final aspect of the resourcing and flexibility improvement phase is the introduction of constraint
management. After identifying the process constraints it is possible to conduct proper planning around
them to maximize system throughput. In most instances of emerging market commercialization efforts,
the constraint is located prior to the file submission or during the business case phase. To execute
constraint management, a Constant Work in Process (CONWIP) system should be established. The
CONWIP system's goal is to pull work through the process by limiting the number of open emerging
market entry jobs in the system at a given time. New emerging market jobs are introduced on a one in,
one out, basis. This means that once the system reaches the CONWIP limit, new work is introduced into
the system only when ajob exits the system, thus creating a pull effect. A CONWIP system is typically
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managed through the use of cards, similar to a kanban card system, but provides less control over
individual process steps. The benefit of the CONWIP system as compared to a kanban system is that it is
less intensive to implement. More information on a CONWIP system can be found in the article,
CONWIP: a pull alternative to kanban by Spearman and Hopp [32]. Generally a reduction of 50-66% of
the average number ofjobs in the current system is an appropriate starting point [33]. This number can
then be refined over time in order to protect the constraint and avoid decreasing throughput. A theoretical
graphical example depicting WIP as an asset or liability is shown in Figure 14. As an example, if the
current system WIP level is 12, a 50-66% reduction would be a CONWIP value of four to six open
commercialization jobs. After implementing the CONWIP system, an improvement in total throughput
time should be attainable. This can also be substantiated through the application of Little's Law, since
there is a direct impact on throughput time when adjustments are made to WIP levels and cycle time is
held constant.
This is the level of WIP that allows
for protection of the Constraint
Asset
WIP Level
When WIP is too
high, we block the
flow of the constraint
resulting in reduced
throughput
When WIP drops too low, we
Liability have to wait between jobs
and reduce throughput
Figure 14: WIP as an Asset or Liability 1331
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The development of all three improvement phases should be conducted in the sequential order discussed
above. If followed, the approach would allow for manageable incremental improvements to be made to
the emerging market commercialization entry process, thus enhancing the efficiency of the overall
process. Figure 15 provides a visual representation of the implementation roadmap discussed in this
section, delineated by implementation phase.
3. Resourcing & FlexibilityI
Pooling & Prioritization







Capacity-Load Planning Ops Efficiency Metrics
(Cost, Speed and Quality)
1. Standardization & Governance
Process Flows & SIPOC Roles & Responsibilities Workflow tool & Project Plans
Figure 15: Implementation Roadmap for Future State Vision of Emerging Market Entry Commercialization
4.5 Control Phase and Future Work Opportunities
The final phase of the Emerging Market Entry Analysis was the control phase. Since a pilot was not
conducted, this phase focused on efforts that could be made to maintain and enhance improvements to the
implementation roadmap as well as opportunities for future work. The first aspect of the control phase
was the recommendation of conducting pilots during and after roadmap implementation. Piloting would
provide valuable insights into how effective the improvements are in terms of tangible metrics as well as
the receptiveness of the organization. The latter of which can heavily influence the results attained in
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measurable improvements. Additionally, piloting would help identify further enhancements that the
organization may desire to include, in addition to those described in the implementation roadmap.
The next aspect of the control phase focused on establishing new or additional measures for continuous
improvement. A number of CTQ's were proposed to better monitor effectiveness of the emerging market
entry commercialization process, yet there may be opportunities to enhance those recommended as the
organization matures in its commercialization efforts. Any newly included metrics should align the
organization to either monitor process performance or to incentivize desired behaviors [4]. It is important
to establish metrics which align with organizational goals if desiring to enhance process effectiveness.
The control phase should conclude by maintaining process policies, procedures and guidelines with those
reflected in the actual process. As improvements or further enhancements are made to the emerging
market commercialization process, it is critical to maintain consistent documentation. Creating new or
refreshing existing documentation supports knowledge retention, the onboarding of new staff,
preparedness for internal or external audits, and most importantly, provides an ongoing basis for
continuous improvement.
4.6 Chapter Summary
The Emerging Market Entry Analysis allowed for the creation of a detailed emerging market entry
commercialization improvement framework with a supporting implementation roadmap, in which the
company can take tangible actions. The Six Sigma DMAIC methodology was an invaluable approach that
supported the planning and creation of the improvement framework. Although a pilot was omitted from
the research area, efforts were made to ensure alignment with organizational plans and receptiveness.
Proof of concept will be required through future pilot efforts and further enhancements can be included by
the company as desired.
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5 Emerging Market Entry Risk Assessment Model (EMERAM)
The Emerging Market Entry Process Analysis facilitated the Emerging Market Entry Risk Assessment
Model (EMERAM) development by providing an in-depth understanding of the commercialization entry
process as well as the pertinent aspects that are critical to the development of a successful model. The end
goal of the model was to develop a robust risk assessment platform which could be used to standardize
risk assessments across the company regions. Additionally, the output of the model endeavored to
enhance management decision making by providing purposeful risk-informed information for entry
decisions into emerging markets. In the following sections, the process for development and integration of
the model into the organization will be discussed.
5.1 Current State Risk Assessment Process Overview
Prior to the project, there was no formally established risk assessment model that existed in the
organization for commercial entry of emerging markets. There was, however, a process in place for a risk
assessment method that integrated the findings of the various functions' country intelligence and due
diligence efforts. The information was then compiled into an assessment to highlight potential risks, but
the analysis was highly dependent upon the resource and region involved. Generally, aspects were
assessed which pertained to Good Manufacturing Practices (GMP) or Good Distribution Practices (GDP),
compliance and regulatory concerns, or distributor suitability matters. The entire risk assessment
methodology was based on subjective determinations of severity of failure and likelihood of occurrence,
without complying with the company risk management standards for making such a valuation. The output
of the previous risk assessment process was escalated to the leadership team in a governance review as
deemed appropriate by the subject matter expert (SME). No formally established process for determining
issues existed, nor was there a cross-functional review of the output to determine if an issue should be
escalated accordingly.
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5.2 Development of a Risk Model for Emerging Market Entry
To initiate the development of the risk assessment model, the first step was to formally define the project
goal and scope of the work to be completed. Since there were many shortcomings in the existing risk
assessment process, it was desired to create a completely new process in which the Emerging Market
Entry Risk Assessment Model (EMERAM) would be the cornerstone. The scope of the new risk
assessment model and supporting process would be limited to the company's non-core markets, primarily
emerging markets. The model would only include existing commercial products in three modes of entry
and would exclude pipeline or developmental products. The three modes of entry as they pertain to the
EMERAM are as follows:
1. New country entry - new product entry into a country which the company does not already
conduct business
2. Existing country entry - new product entry into a country which the company does already
conduct business
3. Pre-Registration Sales - new product entry into a country where the local regulatory agency for
the given country has determined that there is a medical need for a product or products, without
the need to formally commercialize to distribute the product(s). Generally, a grace period is
associated with this mode of entry, lasting between six months to several years.
After defining the project goal and scope, it was necessary to determine the aspects which are relevant to
properly assessing emerging market commercial entry risks. This was a challenging process, as it is
desirable to create a robust model, but also to maintain a proper level of attributes to avoid creating an
overly complex tool. To begin the process, informational interviews and brainstorming workshops were
conducted with the support of SMEs in the operations, regulatory and commercial organizations to attain
anecdotal information regarding aspects that had presented challenges in previous emerging market
launches. This was complimented by a review of the enterprise risk management framework to enhance
the understanding of approaches familiar in the organization and ensure alignment with company risk
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management standards. A detailed review of country launch information followed the framework review,
and included aspects such as the due diligence reports, country intelligence information and business
cases presented during the governance reviews. Additionally, participating in active governance review
meetings supported the collection of pertinent risk aspects. A simultaneous literature review of risk
management techniques and aspects was conducted, reviewing academic works, prior theses on the
subject of risk management, and professional publications. The model was developed using an iterative
process, which involved creating a usable tool and making refinements based on user and workshop
feedback. The above steps support the development of specific elements that should be considered as well
as developing a functional model, which will be discussed in the following section.
5.3 Model Elements and Functionality
This section will review the primary elements and functionality of the EMERAM. The model was
developed using Microsoft Excel to allow for rapid development and revisions without the need for
extensive support of the information systems organization. The EMERAM is intended to standardize and
streamline the risk assessment made for commercial entry into an emerging market country. Using a
scenario-based evaluation methodology with predetermined risk scenarios, the end result of the model
analysis is a risk profile scorecard for a given target entry country. The model is comprised of 109
scenarios which are divided across four focal areas as appropriate. The following describes the four focal
areas:
1. Security and Safety - Aspects relating to risks associated with the reputation and integrity of
company products due to theft, diversion or counterfeiting in the target launch country
2. Quality and Operations - Aspects relating to risks associated with ensuring the quality and
operational standards to ensure uncompromised product efficacy when operationalizing in the
target launch country
3. Regulatory and Compliance - Aspects relating to risks associated with legislative matters
required to conduct business in the target launch country
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4. Business Environment - Aspects relating to risks associated with market potential, geopolitical
stability or intellectual property in the target launch country
Using the Risk Breakdown Structure (RBS) allowed for the creation of 77 risk categories that are divided
across the four focal areas to facilitate a rationale assessment [12]. The risk categories are designed to
align with the risks articulated by the company at an enterprise level. The risk categories and their
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Figure 16: Model Focal Areas and Risk Categories using Risk Breakdown Structure (RBS)
Each scenario is evaluated based on two components of risk consistent with standard risk management
frameworks, such as the Department of Defense (DOD) Risk Management Guide for Acquisition, which
evaluates the severity of failure and likelihood of occurrence [15]. The scenario is scored by a five point
numeric rating criteria using the values 1, 3, 5, 7, and 9 (1 = low and 9 = high) to evaluate severity of
failure and likelihood of occurrence. Detectability of a given scenario, which measures the ability to
recognize a risk, was intentionally omitted since it is not necessarily applicable in all established
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scenarios. Where applicable, the detectability determination is incorporated into the likelihood of
occurrence evaluation, taking into consideration existing mitigation and control efforts. As an example, a
risk scenario that results in an impact to product quality due to a temperature excursion, is detectable
using a control of temperature sensors, whereas a scenario, in which an import test failure occurs, may not
have a control which is detectable. Scenario assessments are established utilizing country intelligence and
due diligence information. The evaluation is made by one or more SME as appropriate based on
individual expertise or functional allocation. Commentary is required for the severity and likelihood score
in order to provide and document rationale as to why a given valuation was made. Generally it is
desirable to have a cross-functional determination of a scenario in order to integrate information that may
be held by a given function and not commonly known to create a cohesive assessment. In instances where
multiple inputs are provided by experts the most conservative valuation is taken, meaning the worst-case
credible outcome is used for the scenario score. For example, if a "likelihood of occurrence" score was
assessed by a quality SME as a nine and by a regulatory SME as a five, the score of nine would be taken
for the scenario evaluation. This presumes that the valuations by each expert were reviewed in sufficient
detail and that the score of nine was, indeed, a credible worst-case outcome. To enhance the ease of use
and standardize the model SMEs have provided recommendations for the severity of failure score for
each established scenario. Justification is included for the severity of failure recommendation to document
how the score was rationalized. This is possible because the model scenarios have been predetermined
and recommendations have been provided under a variety of circumstances. As a result, when conducting
a new assessment for a target entry country, the experts generally only provide input to assess the
likelihood of occurrence as this value will vary significantly between countries. It is possible to deviate
from the recommended severity of failure score, but a reason code should be selected with supporting
rationalization provided, and a detailed review should ensue before a final score is accepted
The risk level for an evaluated scenario is determined using the 5 x 5 risk matrix methodology, in which
varying combinations of severity of failure and likelihood of occurrence risk scores determine a risk level
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score of low, medium or high [14]. The risk level scores and how each corresponds to the selection of











Figure 17: 5 x 5 Risk Matrix and Associated Risk Levels
Risk level scores of low or medium do not require action, but rather it is recommended that low risks are
accepted without need of resolution and medium risks are reviewed to determine if further action may be
warranted. A risk level score of high, mandates that further action is taken in the form of a detailed risk
assessment to determine implementation of controls that minimize, mitigate or eliminate the risk. Risks
which are unable to be remediated must be communicated to senior leadership through the governance
process to determine if it may be deemed appropriate to accept the risk without further action. There is no
time period designation in which a high risk must be escalated or resolved since the risk assessment
model is used to determine perceived potential risks rather than evaluating risks which are currently
actualized by the firm.
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After all scenarios are evaluated and the associated risk levels are produced, a risk profile for each of the
four focal areas is generated to provide a visual representation of the risk assessment. Baseline risk levels
have been established for each risk category within the four focal areas utilizing prior launch data in order
to provide context as to the meaning of the risk profile. A radar diagram chart is used to generate the risk
profile using the maximum risk level score for each scenario in a given risk category. The diagram is
scaled using values of 0, 1, 2 or 3 corresponding to no risk, low risk, medium risk or high risk
respectively. The risk profile is automatically generated in Microsoft Excel and displayed in a dashboard
report to develop a country scorecard. The report is then compiled into a Microsoft PowerPoint template
to generate a management summary which is used at a governance review. An example risk profile is























Figure 18: Example Quality & Operations Risk Profile
57
5.4 Process for Using Model
To support the proper usage of the EMERAM it was necessary to develop process documentation in the
form of guidelines, detailed process maps, definitions and working examples. Below outlines the high
level process steps and a detailed description follows:
1. Risk Scenario Evaluation
2. Generate Risk Level and Risk Profile
3. Cross-functional Output Review
4. Detailed Assessment of High Risk (if applicable)
5. Incorporation of Control Costs or Risk Register Monitoring
To begin, a risk scenario evaluation is made through model inputs that are determined using country
intelligence and due diligence efforts for each focal area as they pertain to the target product(s) or
country. Inputs consist of severity of failure and likelihood of occurrence scores with associated rationale
and where applicable reason codes with associated justification for recommended severity deviations.
Based on the model inputs, risk levels for each individual scenario are generated. Individual risk scenarios
are aggregated into corresponding risk categories where the maximum within a category is taken. A risk
report is generated containing information pertaining to the assessment process utilized, risk level detail
by scenario, and summary information including statistics and risk profiles for each of the four focal
areas. A detailed review meeting of the output is conducted by a cross-functional team of SMEs and leads
for each focal area. Consensus is reached as to the accuracy of the assessment and identification of any
necessary scenarios which require resolution. If a high risk was determined, a detailed risk assessment is
required if it is not readily resolvable and is recommended to be completed using a Failure Modes and
Effects Analysis (FMEA) or comparable methodology [16]. Mitigation or control efforts that are required
in order to reach an acceptable risk level incur significant costs in order to do so and are reflected in the
target country financial analysis or profit and loss statement. Inclusion of considerable costs into the
country profit and loss statement ensures that risk related activities are properly reflected when making a
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decision to enter given target country. When resolution of an identified high-risk scenario is completed,
the scenario is re-evaluated using the severity and likelihood scoring to ensure it has reached an
acceptable risk level. If it is not possible to develop a control for a high-risk scenario, then the risk is
assigned an owner and progress is monitored in a risk register [17]. Utilization of a risk register allows for
a risk portfolio to be created which provides visual representation of risks related to emerging market
entry and can be used to monitor all commercialization activities cross-regionally at a network level. A
process flow of the described process is shown in Figure 19.
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Figure 19: EMERAM Process Flow







To validate the model, four cross-functional pilots were conducted to seek an understanding of
effectiveness and ease of model use, and to make refinements. Utilizing the Toyota Production System
(TPS) methodology, following the scientific method, each pilot was staggered throughout the
development of the model. The approach allowed for incremental improvements to be incorporated before
beginning the next wave of piloting [8]. Additionally, piloting efforts were dispersed across varying
regions, countries and products in order to ensure applicability to all established emerging markets.













viewed as having a complete set of due diligence and country intelligence information. It is worthwhile to
point out that in practice the model will be populated as the commercialization phases progress, yet this
approach was intentionally utilized for piloting to avoid incomplete assessments and potentially omit a
significant risk scenario.
The piloting results determined 4 out of 436 scenarios to be at high risk levels after the cross-functional
model output review. Although the specifics of the identified risks cannot be discussed, the conclusion
from the piloting efforts was that the model is a comprehensive tool that effectively identifies risks
without over or understating a concern. The model provides a standardized approach to conducting a risk
assessment for an emerging market that is detailed in nature without being cumbersome in its use.
Furthermore, it creates a more rigorous assessment that requires significantly less time than the previous
methodology. This is achieved through use of pre-assessed scenarios with recommended severity of
failure scores which are generally exhaustive and applicable to all emerging market launches. Finally, the
model efficiently identifies risks that support either control efforts or further monitoring, provides a risk
profile that is valuable in management decision-making and reflects the cost of control efforts into the
profitability established for a country. Thus, there are tangible financial benefits that are achievable
through the model's continued use and model usage can result in minimal cost implications associated
with expenditures to conduct a risk assessment. Over time, it is possible to develop a repository of
information on past commercial launches which can further enhance the value of the model's impact on
the company.
5.6 Model Limitations and Future Enhancements
The limitations and associated enhancements of the EMERAM span from shortcomings due to the
platform selected for its development to the variability in requirements associated with emerging markets.
One major limitation of the current model is its development in Microsoft Excel. The software is quite
effective at the computational and reporting aspects of the model, but is not easily scalable at an
enterprise level and does not readily support the workflow aspects that are required. Specifically, there is
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limited functionality in gathering input from a large number of experts and compiling the information
without manual intervention. The manual aspect of this process can take a significant amount of time
from an individual and excludes additional time needed for follow-up and feedback efforts that are
expended during execution. Since this is a substantial limitation of the model, there are efforts being made
post-internship to transition the model into Microsoft SharePoint. The transition into the new software
will allow for the establishment of an automated workflow to capture assessment input and provide
notification systems and enhanced reporting functionality.
Another limitation of the model is the fact that not every scenario established is applicable to all launch
instances. This is mainly a consequence of having pre-assessed risk scenarios and various modes of
emerging market country entry that occur in the company. As an example, if the company desires to enter
directly into a country, as opposed to utilizing third parties, then aspects that relate to utility service
integrity are relevant whereas distributor capabilities are not. Due to the current level of sophistication
and experience using the model in the company, it was desired to not filter scenarios by mode of entry.
Future enhancements of the model will incorporate a selection filter by entry type in which a given
selection will only display the applicable scenarios.
An additional model limitation that was intentionally incorporated is the inability to have user generated
risk scenarios. The implications are that aspects which are viewed as special circumstances cannot be
generated by a SME. This was necessary in order to have a standardized risk model for emerging markets
that is consistent in every launch and region. During piloting there were no occurrences of a need to enter
a special circumstance risk that was not captured at a macro level in the risk model, however through
continued use it would be expected that such instances may occur. The current process established to
resolve the omission of new scenario generation is a formal review by the focal area leads to determine
accuracy and applicability, yet it may be more desirable to incorporate a feature to facilitate the ease of
generating a new scenario.
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The remaining enhancements to the model were primarily a function of scope limitation and the need to
integrate them into a developing governance process. One such enhancement would be the incorporation
of interlocks that identify mandatory scenarios which must be completed prior to a certain phase of
governance review. This is similar to the idea of filtering scenarios based on mode of entry, but would
require the determination of scenarios that senior management would like examined prior to a given
governance review phase. Another improvement to the model would be to further refine the generalized
baseline risk profiles that were created by establishing baseline risk profiles for each region. Regional
baselines would allow for a more relevant comparison to the local market and generally be more familiar
to the leadership for a specific region. Finally, as the scope was limited to the commercialization phases
up until product launch and limited to only existing company products, there is an opportunity to extend
the model to post entry considerations as well as pipeline product introduction.
5.7 Sustaining Emerging Market Entry Risk Assessment Model
Although a process was established for the EMERAM's use, it is necessary to develop a plan for
integration into the organization to actualize the model at an enterprise level. This consists of a three-
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The Communication and Integration phase of the roadmap focuses on efforts required to substantiate the
model as a formally agreed upon way of integrating the process in the future. Initially this phase requires
the integration of the proposed EMERAM process into the governance review process as well as any
desired refinements. The proposed process for integration of the model into governance is outlined in
Figure 21. In each commercialization phase a workflow is run of the entire model. In all instances this
occurs five weeks prior to a governance review, with the exception of the Commit to Launch phase which
is conducted three weeks prior to governance and serves as a final validation of the prior phases. Initiators
of the model at each commercialization phase are chosen based on business need or launch commitment.
Two weeks prior to a governance evaluation, focal area leads review the output and high risks are
escalated appropriately. Focal area leads are responsible to ensure control cost efforts are included in
financial analysis or profit and loss statement for the target launch country.
Figure 21: Proposed Process for Model Integration into Governance
The Communication and Integration phase concludes through efforts that are required to communicate the
existence of the model, the approach on how to use it and further socialize the model within the
organization, particularly at a senior leadership level. Finally a cross-functional commitment is needed in
which the output is the establishment of an agreement that officially solidifies the model as a mandatory
step in the process for emerging market entry.
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The next phase of the roadmap, Process Maturity, centers on efforts needed to scale the model to an
enterprise level. The first aspect of this phase strives to develop the Microsoft SharePoint workflow tool
which allows for streamlined usage of the model. Next, necessary maintenance and enhancements to the
model become the goal. These will be driven by the leads for each focal area and based upon feedback
and experiences incurred during model execution. Finally, the phase concludes with the establishment of
risk tier guidance. This concept aims to establish country risk tiers based on a risk to profit ratio. The
numerator of the risk to profit ratio is calculated by summing the product of severity and likelihood for
each risk scenario in a given focal area, then dividing it by the number of risk scenarios in the focal area
and completing this for all four focal areas and taking the total sum. The denominator is based on the
steady state annual profit for the target emerging market entry country. The equation for the risk to profit
ratio is shown below, where i is the focal area number, S is the severity of failure score, L is the
likelihood of occurrence, N is the number of risk scenarios for the focal area, and iu is the profit.
i=4 Zj=Ni Si,j*Li,jRisk j=1 Ni
Profit I
Note: The numerator is divided by N since L, is not a probability
Through continued use of the model, data points can be established which provide meaning through
relative comparisons made to past emerging market entry launches. Tiers of risk can be established based
on the risk to profit ratio and drive further action as needed per risk tier. The overall benefit to the concept
is that risk tier guidance allows the organization to identify a potential high risk entry country when high
risk levels have not been identified for any of the individual risk scenarios.
The final phase of the roadmap, Sustainment, strives to maintain the model and supporting process for
permanent use within the organization. The initial aspect of this phase is to develop a position and appoint
a resource committed to emerging market risk. This role would be performed by an emerging market risk
lead and who would have responsibility for monitoring risks associated with emerging market entry at a
network level across all regions. Additional responsibilities would include: ensuring proper use and
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updates of the model, communicating risks to management and the company risk network and
maintaining documentation associated with the model. The next aspect of this phase is to provide risk
training for facilitators and focal area leads. This is a necessary step in order to support the scalability of
the tool and proper output reviews compliant with company risk standards. Finally, through the prior
steps and appropriate model usage, the organization should be able to attain a level of alignment and
consistency in emerging market entry risk analysis.
5.8 Chapter Summary
The Emerging Market Entry Risk Assessment Model (EMERAM) and supporting processes have
improved the state of the organizations risk analysis through the incorporation of a structured and
repeatable approach. Through the use of pre-determined risk scenarios with recommended severity of
failure scores, a rigorous model has been developed which does not overburden resources in order to gain
valuable output. Four staggered pilots with improvements incorporated into the model between each wave
of piloting supported the proof of concept. While a significant amount of work was conducted by the
author, the true value in the model came from integrating the expertise of all of the SMEs who live the
emerging market entry commercialization process on a daily basis. Without this support, the model would
be very limited and therefore not applicable in many launch instances.
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6 Conclusion and Next Steps
As Amgen continues to pursue its goal of reaching more patients through growth opportunities in
international expansion, rapid emerging market commercialization causes a number of challenges relating
to scalability of current practices and complexities associated within each region. This thesis is comprised
of two strategies, managed in separate research areas, to develop potential solutions to the challenges
encountered, the investigation of improvement opportunities in the commercialization of emerging
markets and the development of a risk assessment model applicable to new market commercial entry.
Each research area proved to be a rather complete and rewarding experience. Though the research areas
were separated in scope, based on specific deliverables to be accomplished, both areas complimented
each other in enhancing the author's understanding and providing a complete depiction of the commercial
process for emerging markets. This was primarily due to the fact that both research areas provided a
solution to the macro problem faced by the organization and international expansion through rapid
emerging market entry. Due to the nature of the project, concluding thoughts and next steps for each
research area will be discussed separately.
6.1 Research Area 1 Conclusion - Emerging Market Entry Process Analysis
The Emerging Market Entry Process Analysis sought to conduct an assessment of improvement
opportunities for emerging market commercialization by providing a tangible set of actions the
organization can take forth in order to enhance the planning and execution of new market entry. The Six
Sigma Process Improvement DMAIC methodology was used as the framework to assess this research
area and report progress to the leadership team. This DMAIC method was selected as it provides a
foundation for a structured project approach, with specific tools that can be utilized and is therefore most
appropriate when the intent of the project is to make enhancements or improve an existing process due to
inadequate performance. The analysis was accomplished through an in depth study to determine the
current level performance for commercial market entry. This consisted of aspects such as the SME
engagement, data analysis, root cause analysis and process improvement tools. The current state analysis
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allowed for a future vision to be established which incorporated fundamental principles of operational
excellence methodologies, integrating various techniques to develop a cohesive approach for improving
current market entry practices.
The results of the Emerging Market Entry Analysis provided a detailed emerging market entry
commercialization improvement framework. A supporting implementation roadmap was created to guide
the organization, specifically the GSC group, in executing a tangible set of actions through incremental
improvements. The goal of the framework is to integrate operational excellence into the commercial entry
process and ultimately improve the planning and execution process for new market entry. Although a
pilot was omitted from the research area, efforts were made to ensure alignment with organizational plans
and receptiveness. A substantial effort was made to communicate and involve cross functional
representation concerning the concepts employed and validation of the proposed methodology for
improvement. Further work is needed in order to formalize the proof of concept through future pilot
efforts. Based on piloting efforts further enhancements to the proposed framework for improved emerging
market entry commercialization can be included based on changes to the international expansion
landscape or as desired by the company.
6.2 Research Area 2 Conclusion - Emerging Market Entry Risk Assessment Model
The Emerging Market Entry Risk Assessment Model (EMERAM) established a tool and a proposal for a
supporting process that integrates the model into the organization to systematically identify risk
associated with emerging market entry. The model complements the governance review process by
providing adequate details on a target country that results in a risk-informed decision making process that
occurs at a senior leadership level as to whether or not a country should be entered. The model utilizes a
scenario based evaluation methodology to integrate cross functional expertise across the organization by
assimilating information that would normally be isolated to a small group within the company. Scenarios
were established through direct engagement of SMEs, reviews of prior launches and literature reviews of
relevant topics including past theses. Risk levels are determined for each scenario, based on the
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combination of severity of failure and likelihood of occurrence, and a risk report is generated. The model
output is reviewed cross functionally with the SMEs that conducted the assessment and functional focal
area leads. Scenarios identified as potentially requiring remediation are reviewed in a detailed risk
assessment and resolved as appropriate. If there is substantial cost associated with control efforts needed
to mitigate a risk, the costs of such activities are incorporated into the financial analysis for the target
launch country. Thus, the model enhances the organization's view of the ramifications associated with
incremental entry of a new country by providing a depiction of cost versus reward for the target launch
country.
The EMERAM and supporting process improves the organization's risk analysis through the
incorporation of a systematically structured and repeatable approach to conducting risk assessments. A
robust model was created through the use of pre-determined risk scenarios with recommended severity of
failure scores that do not overburden resources in order to gain valuable output. Validation of the model
occurred through four staggered pilots with improvements incorporated incrementally between each new
wave of piloting. The results of piloting revealed that a rigorous model was established that does not over
or understate a risk concern. Instead, it provides an accurate depiction of pertinent risks relevant to the
organization if the decision is made to enter a target country. Furthermore, the model developed increases
the firm's ability to make agile risk-informed market entry decisions while providing a standardized
method that is scalable cross regionally. A detailed review of future enhancements of the existing model
was provided in section 5.6, but most notably efforts should be made to transfer the tool from Microsoft
Excel to a platform that better supports the work flow aspects needed for properly scaling the tool at an
enterprise level. Finally, work will need be established to actualize the roadmap for integration, maturity
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